Kostnader för bipolär sjukdom, depression, schizofreni och ångest. Rätt behandlingar kan få stora positiva samhällsekonomiska effekter
Sammanfattning
We present estimates of the societal cost of bipolar disorder, depression, and schizophrenia for patients treated in psychiatric care in Sweden, and add previously unpublished data for generalized anxiety disorder. Retrospective resource use data on outpatient and inpatient care, as well
as ICD-10 diagnoses and Global Assessment of Functioning, were obtained from the Northern Stockholm psychiatric clinic. National registers were used for estimating costs of pharmaceuticals and productivity losses. The yearly cost per patient was 259 000 SEK for bipolar disorder, 159 000
SEK for depression, 156 000 SEK for generalized anxiety disorder and 509 000 SEK for schizophrenia (1 € = 9.23 SEK). The total costs for all four diagnoses were 75 billion SEK in 2008, with indirect costs due to productivity losses representing 75%. The high indirect costs for these
psychiatric diagnoses suggest that treatments which improve functioning have a large potential to reduce the total societal costs.